Filing Details

Accession Number:
0001104659-19-051355
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-25 16:31:27
Reporting Period:
2019-09-23
Accepted Time:
2019-09-25 16:31:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1737953 Replimune Group Inc. REPL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376491 Philip Astley-Sparke C/O Replimune Group, Inc.
18 Commerce Way
Woburn MA 01801
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-09-23 14,500 $17.05 1,427,797 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported on this Form 4 was made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
  2. Following the sale reported on this Form 4, the reporting person continues to beneficially own 1,427,797 shares of the Issuer's common stock. The reporting person also holds options to acquire 382,571 shares of the Issuer's common stock, 87,457 of which are exercisable as of the date hereof.